Annual Drug Patent Expirations for NATESTO
Natesto is a drug marketed by Acerus and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has twenty-eight patent family members in twenty-two countries.
The generic ingredient in NATESTO is testosterone. One supplier is listed for this compound. Additional details are available on the testosterone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
